| RS61778075 |
YRDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Sarcoma, Hepatocellular carcinoma |
| RS61781316 |
LEPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, Obesity due to leptin receptor gene deficiency |
| RS61783968 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS61809332 |
NCF2
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS6181 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61811105 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS61816761 |
FLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Dermatitis, atopic |
| RS61818162 |
IGFN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61825652 |
ATP2B4
|
Health Risk |
Conflicting classifications of pathogenicity |
ATP2B4-related disorder, ATP2B4-related disorder |
| RS61832076 |
SLC30A10
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypermanganesemia with dystonia, polycythemia |
| RS61843232 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS61844226 |
HNRNPU
|
Health Risk |
Likely pathogenic |
— |
| RS61871507 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Sensory ataxic neuropathy, dysarthria |
| RS61873899 |
HPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61886330 |
PLCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 3 |
| RS61889560 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS61890368 |
BBS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, BBS1-related disorder |
| RS61893682 |
INCENP
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS61897383 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 10, Hypertrophic cardiomyopathy |
| RS61900036 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Autosomal recessive nonsyndromic hearing loss 2 |
| RS61910721 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS61926078 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS61935711 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS61935741 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS61941020 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 10, Joubert syndrome 5 |
| RS61952117 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS61957448 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS61966074 |
SLC10A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bile acid malabsorption, primary |
| RS61978561 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, TNXB-related disorder |
| RS61978562 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS61978576 |
EPG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vici syndrome, Inborn genetic diseases |
| RS61978618 |
HEXD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61978638 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS61978648 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
Meniere disease, OTOG-related disorder |
| RS61995753 |
ZNF513
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS61995897 |
SLC25A38
|
Health Risk |
Conflicting classifications of pathogenicity |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS61995907 |
PCLO
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61995921 |
ALG8
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG8 congenital disorder of glycosylation, ALG8-related disorder |
| RS61995923 |
ALG8
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG8 congenital disorder of glycosylation, ALG8-related disorder |
| RS61995958 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS61996282 |
FUCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fucosidosis, Fucosidosis |
| RS61996315 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
Leydig cell agenesis, Gonadotropin-independent familial sexual precocity |
| RS61996318 |
LHCGR
|
Health Risk |
Conflicting classifications of pathogenicity |
LHCGR-related disorder, LHCGR-related disorder |
| RS61996323 |
STXBP5L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61996331 |
RYR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS61996335 |
RYR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, RYR3-related disorder |
| RS61997186 |
RIMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS62000407 |
CENPF
|
Health Risk |
Conflicting classifications of pathogenicity |
CENPF-related disorder, CENPF-related disorder |
| RS62000447 |
TEX15
|
Health Risk |
Pathogenic/Likely pathogenic |
Spermatogenic failure 25, Spermatogenic failure 25 |
| RS62000960 |
COL18A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, COL18A1-related disorder |
| RS62007358 |
VPS13C
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS62052075 |
COX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS62059341 |
CARMIL2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS6207 |
HSD3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
3 beta-Hydroxysteroid dehydrogenase deficiency, HSD3B2-related disorder |
| RS62089120 |
RTTN
|
Health Risk |
Conflicting classifications of pathogenicity |
RTTN-related disorder, RTTN-related disorder |
| RS62095193 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 10 |
| RS62130681 |
CAD
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 50 |
| RS62145939 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS62179016 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
6 conditions, 6 conditions |
| RS62184175 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS62191613 |
OBSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 2, 3M syndrome 2 |
| RS62193615 |
IDH1
|
Health Risk |
Likely pathogenic |
Enchondromatosis, Enchondromatosis |
| RS62208067 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy, Corneal dystrophy-perceptive deafness syndrome |
| RS622288 |
MSTO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome, Inborn genetic diseases |
| RS62242804 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Sick sinus syndrome 1 |
| RS62246206 |
TMIE
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 6, Autosomal recessive nonsyndromic hearing loss 6 |
| RS62261469 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Inborn genetic diseases |
| RS62267114 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS62269092 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal severe primary hyperparathyroidism, Autosomal dominant hypocalcemia 1 |
| RS62286651 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS62295357 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS62296477 |
RNF212
|
Health Risk |
risk factor |
Down syndrome, Down syndrome |
| RS62313245 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS62321379 |
TBCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypotonia, infantile |
| RS62340657 |
TACR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 11 with or without anosmia, TACR3-related disorder |
| RS62346982 |
LRBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to LRBA deficiency, LRBA-related disorder |
| RS62353845 |
NADK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive encephalopathy with leukodystrophy due to DECR deficiency, NADK2-related disorder |
| RS62364883 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Wagner disease, Vitreoretinopathy |
| RS62421010 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Congenital muscular dystrophy due to partial LAMA2 deficiency |
| RS62481073 |
LEP
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to congenital leptin deficiency, Early onset severe obesity |
| RS62481098 |
IMPDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS62492438 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS62506949 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62506950 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62506951 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507260 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507261 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507262 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507265 |
PAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507269 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507270 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507271 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507272 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507279 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507282 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507283 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507286 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507288 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507319 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS62507321 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, PAH-related disorder |